An invalid vocabulary is selected. Please change it in the options.
Title Credits Start date - Expiration datesort ascending
NCCN Guidelines® Insights - T-Cell Lymphomas, Version 1.2021 1.00 11/10/2020 - 12:00am to 11/10/2021 - 12:00am
Archived Monthly Oncology Tumor Boards: A Multidisciplinary Approach to Individualized Patient Care - Gastric Cancer 1.00 11/05/2020 - 12:00am to 11/05/2021 - 12:00am
Recorded Presentation from the NCCN Pharmacy Updates: Establishing a Place in Therapy for Biosimilars in Oncology 1.00 11/05/2020 - 12:00am to 11/05/2021 - 12:00am
Optimizing Outpatient Care in Hematopoietic Cell Transplant Patients 0.75 10/30/2020 - 12:00am to 10/30/2021 - 12:00am
Strategies to Reduce Clostridioides Difficile Infection in Hematologic Malignancies 0.75 10/30/2020 - 12:00am to 10/30/2021 - 12:00am
Management of Cardiac Complications in Hematologic Malignancies 0.75 10/30/2020 - 12:00am to 10/30/2021 - 12:00am
Advances and Innovations in Multiple Myeloma 0.75 10/30/2020 - 12:00am to 10/30/2021 - 12:00am
Lymphoma 101: The Plot Thickens 0.50 10/30/2020 - 12:00am to 10/30/2021 - 12:00am
Navigating the Jargon of Molecular Testing 0.50 10/30/2020 - 12:00am to 10/30/2021 - 12:00am
Controversies in the Management of Early-Stage Hodgkin Lymphoma 0.50 10/30/2020 - 12:00am to 10/30/2021 - 12:00am
Updates in the Management of Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: Sequencing Therapy and the Role of MRD Testing 0.50 10/30/2020 - 12:00am to 10/30/2021 - 12:00am
Challenges and Opportunities in Marginal Zone Lymphoma: Implications of Biology on Treatment 0.50 10/30/2020 - 12:00am to 10/30/2021 - 12:00am
Relapsed/Refractory Diffuse Large B-Cell Lymphoma and Mantle Cell Lymphoma: Is it Time to Consider CAR T for All? 0.50 10/30/2020 - 12:00am to 10/30/2021 - 12:00am
Peripheral T-Cell Lymphomas-Not Otherwise Specified: A Shrinking Entity? 0.50 10/30/2020 - 12:00am to 10/30/2021 - 12:00am
Emerging Therapeutic Options in Acute Lymphoblastic Leukemia 0.50 10/30/2020 - 12:00am to 10/30/2021 - 12:00am

Pages